drugset / Trial / NCT02627131
Autologous Bone Marrow Stem Cell Therapy for Autism
NaSingle-groupOpen-labelTreatment
Summary
The aim of this study was to evaluate the safety and effectiveness of autologous bone marrow mononuclear stem cells in the management of autism.
Timeline
- Start
- 2014-04
- Primary completion
- 2015-12
- Completion
- 2015-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | autologous bone marrow mononuclear cells | Cell therapy | — | Intrathecal |